Inactive Instrument

501 ACQU Stock price

Equities

FVAM

US33836P1057

Dynamic Chart
5:01 Acquisition Corp.(NasdaqCM:FVAM) dropped from NASDAQ Composite Index CI
5:01 Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
5:01 Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
5:01 Acquisition Corp. Announces Resignation of Martin Mackay as A Member of the Board of Directors CI
5:01 Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
5:01 Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
5:01 Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
5:01 Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
5:01 Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
5:01 Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Certain Class B Common Stock of 5:01 Acquisition Corp. are subject to a Lock-Up Agreement Ending on 12-APR-2021. CI
5:01 Acquisition Corp. Reports Earnings Results for the Period from August 31, 2020 to December 31, 2020 CI
5:01 Acquisition Corp. announced that it has received $3.6 million in funding from 5:01 Acquisition LLC CI
5:01 Acquisition Corp. has completed an IPO in the amount of $80 million. CI
5:01 Acquisition Corp. has filed an IPO in the amount of $80 million. CI
More news
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO 52 20-08-31
General Counsel 47 20-08-31
Members of the board TitleAgeSince
Director/Board Member 52 20-09-30
Director/Board Member - 20-10-31
More insiders
5:01 Acquisition Corp is a blank check company. The Company is created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. The Company focuses on early stage North American or European companies in the biotechnology sector of the healthcare industry. The Company has no operations and has not generated revenues.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock 501 ACQU - Nasdaq